One-stage surgery beats two-stage for unresectable liver metastases.

  • Median overall survival was 46.5 months for one-stage versus 34.0 months for two-stage (p = 0.043).
  • Complication rates were similar: 11% for one-stage and 13% for two-stage (p = 0.567).
  • Local treatment was more successful with one-stage surgery, achieving complete resection or ablation in 52 patients compared to 29 in the two-stage group (p < 0.001).

Consider one-stage approaches as a first option for eligible patients, with two-stage surgery reserved for more complex cases.

Comparative Study by Bond MJG, Bolhuis K (…) Swijnenburg RJ et 23 al. in BJS Open

© The Author(s) 2025. Published by Oxford University Press on behalf of BJS Foundation Ltd.

read the whole article in BJS Open

open it in PubMed